FDA Commissioner Marty Makary Resigns: A Look Back at His Turbulent Tenure
The FDA Commissioner, Marty Makary, is resigning from his position after facing challenges during his 13-month tenure. The decision to replace Makary with Kyle Diamantas, a former top food official at the agency, was made by HHS Secretary Robert F. Kennedy Jr. Makary's time at the FDA was characterized by layoffs, leadership turnover, and policy disputes with various stakeholders.
Despite the decision being months in the making, Makary had public appearances scheduled and was quoted in agency press releases until his resignation. The White House had to approve the decision, but Secretary Kennedy ultimately made the call. Makary faced criticism from anti-abortion Republicans, pressure from President Trump to authorize flavored vapes, and backlash from biopharmaceutical companies over the agency's review process.
The departure of Marty Makary as FDA Commissioner was influenced by a series of events that highlighted the challenges he faced during his tenure. The decision to replace him with Kyle Diamantas in an acting capacity marks the end of Makary's time leading the federal agency.